Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the following conferences during January and February 2023:
- Redeye Fight Cancer Day 2023, January 19, Stockholm
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
- Aktiespararna "Aktiedagen i Lund", January 31, Lund
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
- ØU Life Science Investor Conference, February 22, Copenhagen, Denmark
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
- European Bispecific & Multispecific Antibody Congress, February 22 – 23, Amsterdam, Netherlands
Laura von Schantz, Vice President of Discovery at Alligator Bioscience, will give a presentation entitled "Reviewing the Landscape of Obligate MoAs for Bi-/Multispecifics to Prioritise and De-Risk Current and Future Efforts" at 2.30 pm CET on February 22.Registration for the conference is open here.
The information was submitted for publication, through the agency of the contact persons set out below, at 8:00 a.m. CET on January 9, 2023.